V
Company Profile
ViewsML
A platform that uses AI to derive biomarker insights from pathology images of human tissue samples.
Canadian company (BC)1
Dispatches
Apr 21, 2026
Latest story
Editorial lens
Why Boreal Signal tracks this company
We track ViewsML to understand how its decisions in ai-powered computational layer for deriving biomarker insights from pathology images. affect the market and its Canadian operations.
Profile facts
- Coverage focus
- AI-powered computational layer for deriving biomarker insights from pathology images.
- Related stories
- 1
- Last reviewed
- Jul 31, 2026
Profiles are based on Boreal Signal reporting and are updated as new stories are published.
All stories about this company
ViewsML Builds Computational Layer for Virtual Biomarker Diagnostics
ViewsML Builds Computational Layer for Virtual Biomarker Diagnostics
Kenneth To and his team at ViewsML are tackling one of the persistent, high-friction bottlenecks in modern precision medicine: the sheer labor and cost associated with traditional tissue analysis. Their ambiti...
Read article